The impact of the BMI on the severity of steatosis in NAFLD cases seems to depend partly on the FATP5 polymorphism, but additional studies are needed to define the association with progressive liver damage. The gene discussed is SLC27A5; the disease is metabolic dysfunction-associated steatotic liver disease.